Company Overview
- Primary Stem Cells | Advanced Animal Models | End-to-End Services
ABOUT US
Axiocell Biotech Sdn Bhd is a specialized preclinical solution provider advancing drug discovery, regenerative medicine, and precision research through clinically relevant in vitro and in vivo platforms. We offer a comprehensive portfolio of disease-specific and humanized animal models, primary human cells, including CD34⁺ hematopoietic stem cells and immune cells, as well as tailored preclinical services and high-quality reagents and culture media.
Our integrated research ecosystem is designed to deliver clinically meaningful results with speed and cost-efficiency. Whether you’re optimizing a novel therapeutic, evaluating safety and efficacy, or developing a cell-based therapy, Axiocell provides the scientific expertise and customized tools needed to accelerate your innovation from bench to bedside.
Trusted by academic, biotech, and pharmaceutical partners across the region, Axiocell is committed to delivering high-quality, flexible solutions that drive translational success and support impactful discoveries.
OUR EXPERTISE
Excellence in Preclinical Research
At Axiocell Biotech, we are committed to delivering excellence through every step of your preclinical journey. Our foundation is built on rigorous scientific standards, technical precision, and a deep understanding of translational research. With a dedicated team of scientists and specialists, we ensure every model, cell product, and service meets the highest quality benchmarks—empowering you to generate reliable, clinically meaningful results. Our expertise spans three core areas:
Stem Cells
We provide high-quality and ethically sourced stem cells (MSC / HSC), autologous MNC to support applications in humanized mice production, regenerative and immune research.
Animal Models
We provide well-characterized, disease-specific, immunodeficient and humanized in vivo models that mimic human pathophysiology to improve translational success.
Preclinical Services
From custom study design to technical execution, we deliver flexible and cost-effective preclinical services for drug discovery, efficacy testing, and cell-based therapy development.
Culture Media & Reagents
We supply high-quality, cost-effective, and validated media, reagents, and consumables, with customization options for stem cells, HEK293, CHO cells, immune cells, and routine preclinical workflows.
Our Mission
To build long-term partnerships with academia, biotech, and pharmaceutical researchers by providing high-quality, cost-effective, and clinically relevant animal models, primary human cell products, and tailored preclinical services.
Our Vision
To be the leading provider of clinically relevant preclinical solutions that accelerate the development of safer, more effective therapies for global healthcare advancement.
With several decades of experience in preclinical research, we understand the challenges you face. Axiocell’s role is to accelerate your research by providing tailored, high-quality solutions that align with your needs. Our principles are aligned with the five core values outlined:
Quality Excellence
Clinical Relevance
Integrity and Transparency
Regulatory Compliance
Collaboration for Innovation
Flexibility
Book an Appointment with Our Experts Today
Book your free consultation with our scientists today and discover the difference of personalized, expert research support tailored to your needs!
Axiocell Biotech Sdn Bhd.
Suite 2-5, Level 18, Plaza Azalea 10, Persiaran Bandaraya, Seksyen 14, 40000 Shah Alam, Selangor.
© 2025 AXIOCELL BIOTECH. All rights reserved.
Developed by Infinicore – Design by LeMoon